Numico ephedra litigation
This article was originally published in The Tan Sheet
Executive Summary
The number of active ephedra cases at both GNC and Rexall Sundown increased by 10 since the beginning of March, "a continuation of the stable trend witnessed over the last 18 months," according to former parent company Royal Numico. The Dutch firm maintains that its occurrence-based insurance policy remains adequate in covering litigation risk, and that the probability of new lawsuits "is less likely" given that it halted ephedra sales last June. Numico reported 137 ephedra liability lawsuits in March (1"The Tan Sheet" March 8, 2004, p. 10)...
You may also be interested in...
GNC Liability In Ephedra Lawsuits Is Limited, Numico Says
Rexall Sundown and GNC have been named in 137 product liability lawsuits involving ephedrine alkaloid-containing dietary supplements, former parent company Royal Numico disclosed in a year-end financials release March 4
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.